Literature DB >> 34453882

Relationship of ejection fraction and natriuretic peptide trajectories in heart failure with baseline reduced and mid-range ejection fraction.

Kenneth C Bilchick1, Patrick Stafford2, Olusola Laja2, Comfort Elumogo2, Persey Bediako2, Nora Tolbert2, Douglas Sawch2, Sthuthi David2, Nishtha Sodhi2, Anita Barber2, Younghoon Kwon3, Nishaki Mehta4, Brandy Patterson2, Khadijah Breathett5, Sula Mazimba2.   

Abstract

BACKGROUND: The prognostic importance of trajectories of neurohormones relative to left ventricular function over time in heart failure with reduced and mid-range EF (HFrEF and HFmrEF) is poorly defined.
OBJECTIVE: To evaluate left ventricular ejection fraction (LVEF) and B-type natriuretic peptide (BNP) trajectories in HFrEF and HFmrEF.
METHODS: Analyses of LVEF and BNP trajectories after incident HF admissions presenting with abnormal LV systolic function were performed using 3 methods: a Cox proportional hazards model with time-varying covariates, a dual longitudinal-survival model with shared random effects, and an unsupervised analysis to capture 3 discrete trajectories for each parameter.
RESULTS: Among 1,158 patients (68.9 ± 13.0 years, 53.3% female), both time-varying LVEF measurements (P=.001) and log-transformed BNP measurements (p-values=2 × 10-16) were independently associated with survival during 6 years after covariate adjustment. In the dual longitudinal/survival model, both LVEF and BNP trajectories again were independently associated with survival (P<.0001 in each model); however, LVEF was more dynamic than BNP (P <.0001 for time covariate in LVEF longitudinal model versus P=.88 for the time covariate in BNP longitudinal model). In the unsupervised analysis, 3 discrete LVEF trajectories (dividing the cohort into approximately thirds) and 3 discrete BNP trajectories were identified. Discrete LVEF and BNP trajectories had independent prognostic value in Kaplan-Meier analyses (P<.0001), and substantial membership variability across BNP and LVEF trajectories was noted.
CONCLUSION: Although LVEF trajectories have greater temporal variation, BNP trajectories provide additive prognostication and an even stronger association with survival times in heart failure patients with abnormal LV systolic function.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34453882      PMCID: PMC8633031          DOI: 10.1016/j.ahj.2021.08.015

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  31 in total

1.  Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.

Authors:  Andreas P Kalogeropoulos; Gregg C Fonarow; Vasiliki Georgiopoulou; Gregory Burkman; Sarawut Siwamogsatham; Akash Patel; Song Li; Lampros Papadimitriou; Javed Butler
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

2.  Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups.

Authors:  Andreas Martinsson; Petter Oest; Maj-Britt Wiborg; Öyvind Reitan; J Gustav Smith
Journal:  Scand Cardiovasc J       Date:  2018-04-14       Impact factor: 1.589

3.  Group-based trajectory modeling: an overview.

Authors:  Daniel S Nagin
Journal:  Ann Nutr Metab       Date:  2014-11-18       Impact factor: 3.374

Review 4.  Refining Classification of Heart Failure Based on Ejection Fraction.

Authors:  Gregg C Fonarow
Journal:  JACC Heart Fail       Date:  2017-11       Impact factor: 12.035

5.  Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.

Authors:  Gianluigi Savarese; Ola Vedin; Domenico D'Amario; Alicia Uijl; Ulf Dahlström; Giuseppe Rosano; Carolyn S P Lam; Lars H Lund
Journal:  JACC Heart Fail       Date:  2019-03-06       Impact factor: 12.035

6.  Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction.

Authors:  Shannon M Dunlay; Véronique L Roger; Susan A Weston; Ruoxiang Jiang; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2012-08-30       Impact factor: 8.790

Review 7.  Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.

Authors:  Justin B Echouffo-Tcheugui; Sebhat Erqou; Javed Butler; Clyde W Yancy; Gregg C Fonarow
Journal:  JACC Heart Fail       Date:  2015-12-09       Impact factor: 12.035

Review 8.  Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete?

Authors:  Michael R Bristow; David P Kao; Khadijah K Breathett; Natasha L Altman; John Gorcsan; Edward A Gill; Brian D Lowes; Edward M Gilbert; Robert A Quaife; Douglas L Mann
Journal:  JACC Heart Fail       Date:  2017-11       Impact factor: 12.035

9.  Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.

Authors:  Minjae Yoon; Pil-Sung Yang; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Thromb Haemost       Date:  2018-05-03       Impact factor: 5.249

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

View more
  1 in total

1.  Cardiac magnetic resonance defines mechanisms of sex-based differences in outcomes following cardiac resynchronization therapy.

Authors:  Derek J Bivona; Srikar Tallavajhala; Mohamad Abdi; Pim J A Oomen; Xu Gao; Rohit Malhotra; Andrew Darby; Oliver J Monfredi; J Michael Mangrum; Pamela Mason; Sula Mazimba; Michael Salerno; Christopher M Kramer; Frederick H Epstein; Jeffrey W Holmes; Kenneth C Bilchick
Journal:  Front Cardiovasc Med       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.